The best-selling product of our CNS portfolio, and at the same time one of Richter's best known original products is Cavinton. The product, which is the result of more than 20 years of R&D work, is used in the treatment of chronic cerebral circulatory disorders and has been on the market for forty years.
The latest addition to the portfolio is our proprietary antipsychotic which has become a blockbuster in the US. Learn more about cariprazine.
In addition, our central nervous system drugs include anaesthetics, anti-anxiety medications, sleeping pills, modern anti-epileptic medicines as well as a product for treating neuropathic pain.
The strategic objective for Richter is to provide a continuously expanding product line in this segment too.